ЭФФЕКТИВНОСТЬ РИТУКСИМАБА ПРИ СИНДРОМЕ СТИЛЛА У ВЗРОСЛОГО ПАЦИЕНТА (ОПИСАНИЕ СЛУЧАЯ)
https://doi.org/10.14412/1995-4484-2010-736
Об авторах
Г. М. ТарасоваРимма Михайловна Балабанова
Е. Г. Сажина
Юрий Алексанрович Олюнин
Евгений Львович Насонов
Список литературы
1. <div><p>Yamaguchi M., Ohta A., Tsunematsu T. et al. Preliminary criteria for classification of adult onset Still's disease. J Rheumatol 1992; 19: 424-30.</p><p>Hamidou M.A., Denis M., Barbarot S. et al. Usefulness of glycosylated ferritin in atypical presentations of adult onset Still's disease. Ann Rheum Dis 2004; 63: 605.</p><p>Sono H., Matsuo K., Miyazato H. et al. A case of adult onset Still's disease complicated by non-Hodgkin's lymphoma. Lupus 2000; 9: 468-70.</p><p>Fautrel B., Sibilia J., Mariette X. et al. Tumor necrosis factor a blocking agents in refractery adult Still's disease; an observation study of 20 cases. Ann Rheum Dis 2005; 64(2): 262-6.</p><p>Lequerre T., Quartier P., Rosselini D. et al. IL-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still's disease. Ann Rheum Dis 2008; 67(3): 302-8.</p><p>De Bandt M., Saint-Marcos B. Tocilizumab for multirefractory adult onset Still's disease. Ann Rheum Dis 2009; 68: 153-4.</p><p>Ahmadi-Simab K., Lamprecht P., Jankowiak C. et al. Successful treatment of refractory adult onset Still's disease with retuхimab. Ann Rheum Dis 2006; 65: 1117-8.</p><p>Nissen M.I., Fontanges E., Allam Y. et al. Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotreхate and interferon. Reumatology (Oxford) 2005; 44(8): 1016-20.</p><p>Chuang E., Del Vecchio A., Smolinski S. et al. Biomedicins to reduce inflamation but not viral load in chronic HCV-what's the cause? Trends Biotechnol 2004; 22(10): 517- 23.</p><p>Antonelli A., Ferry C., Galeazzi M. et al. HCV-infection: pathogenesis, clinical manifestation and therapy. Clin Exp Rheum 2008; 26(1): 39-47.</p><p>Efthimiou P., Georgy S. Pathogenesis and management of AOSD. Semin Arthr Rheum 2006; 36: 144-52.</p><p>Bartoloni E., Alunno A., Luccioli F. et al. Successful treatment of refractory adult- onset Still's disease with anti-CD20 monoclonal antibody. Clin Exper Rheum 2009; 27(5): 888-9.</p></div><br />
Рецензия
Для цитирования:
Тарасова Г.М., Балабанова Р.М., Сажина Е.Г., Олюнин Ю.А., Насонов Е.Л. ЭФФЕКТИВНОСТЬ РИТУКСИМАБА ПРИ СИНДРОМЕ СТИЛЛА У ВЗРОСЛОГО ПАЦИЕНТА (ОПИСАНИЕ СЛУЧАЯ). Научно-практическая ревматология. 2010;48(5):85-88. https://doi.org/10.14412/1995-4484-2010-736
For citation:
Tarasova G.M., Balabanova R.M., Sazhina E.G., Olyunin Yu.A., Nasonov E.L. EFFEKTIVNOST' RITUKSIMABA PRI SINDROME STILLA U VZROSLOGO PATsIENTA (OPISANIE SLUChAYa). Rheumatology Science and Practice. 2010;48(5):85-88. (In Russ.) https://doi.org/10.14412/1995-4484-2010-736